Preventing Recurrence of Hepatocellular Carcinoma After Curative Hepatectomy With Active Hexose-correlated Compound Derived From Lentinula edodes Mycelia.
Toshiya KamiyamaTatsuya OrimoKenji WakayamaTatsuhiko KakisakaShingo ShimadaAkihisa NagatsuYoh AsahiTakeshi AiyamaHirofumi KamachiAkinobu TaketomiPublished in: Integrative cancer therapies (2022)
AHCC may be safe and effective in preventing HCC recurrence after curative hepatectomy, and further randomized trials of AHCC for its use in this setting are warranted.This clinical trial was registered in UMIN Clinical Trials Registry (ID UMIN000024396).